Published in Lancet on June 23, 1979
Tissue distribution and anti-inflammatory activity of corticosteroids incorporated in lipid emulsion. Ann Rheum Dis (1982) 1.54
Progress in intra-articular therapy. Nat Rev Rheumatol (2013) 1.24
Treatment of experimental arthritis with poly(D, L-lactic/glycolic acid) nanoparticles encapsulating betamethasone sodium phosphate. Ann Rheum Dis (2005) 0.88
HIV surveillance by testing saliva. AIDS (1988) 3.43
Shoulder disorders in the elderly: a community survey. Arthritis Rheum (1991) 3.21
Azathioprine in rheumatoid arthritis. Br Med J (1969) 3.14
Supervision of epileptic patients taking phenytoin. Br Med J (1970) 3.09
Prognosis and management of polymyalgia rheumatica. Ann Rheum Dis (1981) 3.08
Thermographic changes in keyboard operators with chronic forearm pain. BMJ (1997) 2.90
Oral contraceptives, antithrombin- III activity, and postoperative deep-vein thrombosis. Lancet (1976) 2.77
Preventing Rh immunisation. BMJ (1994) 2.70
Frozen shoulder: a long-term prospective study. Ann Rheum Dis (1984) 2.67
Polymyalgia rheumatica -- a clinical study with particular reference to arterial disease. J Rheumatol (1974) 2.66
Frozen shoulder: prospective clinical study with an evaluation of three treatment regimens. Ann Rheum Dis (1984) 2.60
Shoulder disorders in the elderly (a hospital study). Ann Rheum Dis (1987) 2.45
Extracorporeal shock wave therapy for lateral epicondylitis--a double blind randomised controlled trial. J Orthop Res (2002) 2.40
Extracorporeal shock wave therapy for plantar fasciitis. A double blind randomised controlled trial. J Orthop Res (2003) 2.38
The painful stiff shoulder. Rheumatol Phys Med (1972) 2.37
Measurement of fibrinogen and fibrin degradation products in serum by staphylococcal clumping test. J Lab Clin Med (1970) 2.21
The Royal Flying Doctor Service of Australia: its foundation and early development. Med J Aust (1994) 2.03
Specific learning disability in children with neurofibromatosis type 1: significance of MRI abnormalities. Neurology (1994) 2.03
Sailors, scurvy and science. J R Soc Med (1997) 1.94
Lymphocyte proliferation to artery antigen as a positive diagnostic test in polymyalgia rheumatica. Ann Rheum Dis (1975) 1.94
5-hydroxytryptamine in the circulation of the dog. Nature (1967) 1.88
A prospective double blind dummy placebo controlled study comparing triamcinolone hexacetonide injection with oral diclofenac 50 mg TDS in patients with rotator cuff tendinitis. J Rheumatol (1990) 1.87
Wound healing after operations of patients with rheumatoid arthritis. J Bone Joint Surg Br (1973) 1.86
Erythrocyte sedimentation rate and C reactive protein in the assessment of polymyalgia rheumatica/giant cell arteritis on presentation and during follow up. Ann Rheum Dis (1989) 1.81
Liver disease and common-bile-duct stenosis in cystic fibrosis. N Engl J Med (1988) 1.79
Tennis elbow--a reappraisal. Br J Rheumatol (1989) 1.76
Bacterial joint infections in England and Wales: analysis of bacterial isolates over a four year period. Br J Rheumatol (1997) 1.76
The clinical significance of blood group antibodies. Transfus Med (2002) 1.76
Treatment of polymyalgia rheumatica and giant cell arteritis. II. Relation between steroid dose and steroid associated side effects. Ann Rheum Dis (1989) 1.74
Rotator cuff degeneration and lateral epicondylitis: a comparative histological study. Ann Rheum Dis (1994) 1.73
Humanised monoclonal antibody therapy for rheumatoid arthritis. Lancet (1992) 1.72
The interaction of purified rabbit bone collagenase with purified rabbit bone metalloproteinase inhibitor. Biochem J (1983) 1.72
Extracorporeal shock-wave therapy for tendonitis of the rotator cuff. A double-blind, randomised, controlled trial. J Bone Joint Surg Br (2002) 1.71
The long-term outcome of rotator cuff tendinitis--a review study. Br J Rheumatol (1988) 1.69
Morbidity and mortality in rheumatoid arthritis patients with prolonged and profound therapy-induced lymphopenia. Arthritis Rheum (2001) 1.67
Treatment of polymyalgia rheumatica and giant cell arteritis. I. Steroid regimens in the first two months. Ann Rheum Dis (1989) 1.66
Treatment of refractory Wegener's granulomatosis with humanized monoclonal antibodies. QJM (1996) 1.66
Complete cartilage-ring tracheal stenosis associated with anomalous left pulmonary artery: the ring-sling complex. Radiology (1984) 1.64
The measurement of collagenase, tissue inhibitor of metalloproteinases (TIMP), and collagenase-TIMP complex in synovial fluids from patients with osteoarthritis and rheumatoid arthritis. Arthritis Rheum (1993) 1.62
Diagnosis and relation to general health of shoulder disorders presenting to primary care. Rheumatology (Oxford) (2005) 1.61
Experiment versus authority. N Engl J Med (1969) 1.59
Tendon degeneration and chronic shoulder pain: changes in the collagen composition of the human rotator cuff tendons in rotator cuff tendinitis. Ann Rheum Dis (1994) 1.58
Cause of death in patients with rheumatoid arthritis with particular reference to azathioprine. Ann Rheum Dis (1980) 1.57
Antibodies to intermediate filaments in polymyalgia rheumatica and giant cell arteritis: a sequential study. Ann Rheum Dis (1987) 1.54
Radioiodine treatment of Graves' disease in young people. Horm Res (1998) 1.48
Lateral humeral epicondylitis--a study of natural history and the effect of conservative therapy. Br J Rheumatol (1983) 1.46
Is therapeutic ultrasound effective in treating soft tissue lesions? Br Med J (Clin Res Ed) (1985) 1.46
How complete is a transurethral resection of the prostate? Br J Urol (1996) 1.45
Structure of full-length porcine synovial collagenase reveals a C-terminal domain containing a calcium-linked, four-bladed beta-propeller. Structure (1995) 1.44
Treatment of pulmonary embolic disease. A critical review of some aspects of current therapy. N Engl J Med (1965) 1.44
Glycosaminoglycans of human rotator cuff tendons: changes with age and in chronic rotator cuff tendinitis. Ann Rheum Dis (1994) 1.43
Azathioprine in giant cell arteritis/polymyalgia rheumatica: a double-blind study. Ann Rheum Dis (1986) 1.42
Lymphocyte sensitivity to skeletal muscle in patients with polymyositis and other disorders. Clin Exp Immunol (1973) 1.41
Immunological studies in frozen shoulder. J Rheumatol (1983) 1.38
Efficacy of low-dose heparin in prevention of extensive deep-vein thrombosis in patients undergoing total-hip replacement. Lancet (1976) 1.38
Metalloproteinases and collagenase inhibitors in rheumatoid synovial fluid. Arthritis Rheum (1984) 1.31
Community survey of shoulder disorders in the elderly to assess the natural history and effects of treatment. Ann Rheum Dis (1995) 1.31
Increased expression of aggrecan and biglycan mRNA in Achilles tendinopathy. Rheumatology (Oxford) (2005) 1.30
Acquired dysfibrinogenaemia in acute and chronic liver disease. Br J Haematol (1977) 1.30
HLA-B27 and frozen shoulder. Lancet (1976) 1.29
Evaluation of mannitol, lactulose and 51Cr-labelled ethylenediaminetetra-acetate as markers of intestinal permeability in man. Clin Sci (Lond) (1987) 1.27
A double-blind trial comparing subacromial methylprednisolone and lignocaine in acute rotator cuff tendinitis. Br J Rheumatol (1993) 1.26
Calcific tendinitis of the shoulder. N Engl J Med (1999) 1.25
Immunological and histological study of temporal arteries. Ann Rheum Dis (1978) 1.24
Blood platelet nucleotides in man and other species. Nature (1969) 1.24
Localized scleroderma and hemiatrophy in association with antibodies to double-stranded DNA. Postgrad Med J (1992) 1.23
Liposome-incorporated corticosteroids: I. The interaction of liposomal cortisol palmitate with inflammatory synovial membrane. Br J Exp Pathol (1979) 1.22
Human shoulder tendon biopsy samples in organ culture produce procollagenase and tissue inhibitor of metalloproteinases. Ann Rheum Dis (1995) 1.22
Current status of immunoprophylaxis with anti-D immunoglobin. Vox Sang (2003) 1.22
The presentation and management of individuals contaminated with solutions of dibenzoxazepine (CR). Med Sci Law (1973) 1.21
Frozen shoulder: an arthrographic and radionuclear scan assessment. Ann Rheum Dis (1984) 1.20
Measurement of rheumatoid factors by an enzyme-linked immunosorbent assay (ELISA) and comparison with other methods. Ann Rheum Dis (1985) 1.20
Fibrin degradation products in pre-eclamptic toxaemia and eclampsia. Br Med J (1970) 1.20
Effect of catecholamines on platelet aggregation caused by thrombin. Nature (1967) 1.20
Factors relating to circulating immune complexes in rheumatoid arthirits. Ann Rheum Dis (1976) 1.20
Periodontal disease status during pregnancy and 3 months post-partum, in a rural population of Sri-Lankan women. J Clin Periodontol (2000) 1.18
Effect of exercise training on passive stiffness in locomotor skeletal muscle: role of extracellular matrix. J Appl Physiol (1985) (1998) 1.18
Shoulder pain in a community-based rheumatology clinic. Br J Rheumatol (1995) 1.17
A therapeutic human IgG4 monoclonal antibody that depletes target cells in humans. Clin Exp Immunol (1996) 1.15
Inhibition of tendon cell proliferation and matrix glycosaminoglycan synthesis by non-steroidal anti-inflammatory drugs in vitro. J Hand Surg Br (2001) 1.14
A comparative study of four methods for detecting fibrinogen degradation products in patients with various diseases. N Engl J Med (1970) 1.14
Long-term azathioprine in rheumatoid arthritis: a double-blind study. Ann Rheum Dis (1981) 1.13
Relationship of the erythrocyte sedimentation rate to acute phase proteins in polymyalgia rheumatica and giant cell arteritis. Ann Rheum Dis (1981) 1.13
Bone mechanical properties after exercise training in young and old rats. J Appl Physiol (1985) (1990) 1.13
Collagenase (MMP-1) and TIMP-1 in destructive corneal disease associated with rheumatoid arthritis. Eye (Lond) (1995) 1.12
Autoantibodies in malaria, tuberculosis and hepatitis B in a west African population. Clin Exp Immunol (1993) 1.10
Arthro-osteitis--a clinical spectrum. Br J Rheumatol (1993) 1.10
Role of platelets in the acute pulmonary responses to endotoxin. J Appl Physiol (1967) 1.10
Osteitis pubis and instability of the pubic symphysis. When nonoperative measures fail. Am J Sports Med (2000) 1.10
Thromboprophylaxis after replacement arthroplasty. BMJ (2001) 1.10
Plasma heparin levels after administration of calcium and sodium salts of heparin. Thromb Res (1976) 1.09
Some guidelines for heparin therapy of venous thromboembolic disease. JAMA (1967) 1.09
The comparative incidence of malignant disease in rheumatoid arthritics exposed to different treatment regimens. Ann Rheum Dis (1982) 1.09
Prevalence and possible pathological significance of calcium phosphate salt accumulation in tendon matrix degeneration. Ann Rheum Dis (1996) 1.08
Fate of embryonic stem cells transplanted into the deafened mammalian cochlea. Cell Transplant (2006) 1.07
Novel treatment for joint inflammation. Nature (1978) 1.07
Monoclonal antibodies against human fibroblast collagenase and the design of an enzyme-linked immunosorbent assay to measure total collagenase. Matrix (1992) 1.07
Pathogenesis of venous thrombosis in relation to its prevention by dextran and heparin. J Lab Clin Med (1965) 1.06